收藏切换
Construction of an aging mouse model induced by different doses of doxorubicin
收藏切换
PDF
Hong YAN1, 2, 3, Lyudong GONG1, 2, 3, Chengzhi ZHONG1, 2, 3, Zhida ZI1, 2, 3, Ting LI1, 2, 3, Desong WU1, 2, 3, Yan GUO1, 2, 3, *
Acta Laboratorium Animalis Scientia Sinica | 2026, 34(3) : 371 - 381
Less
收藏切换
Acta Laboratorium Animalis Scientia Sinica | 2026, 34(3): 371-381
Construction of an aging mouse model induced by different doses of doxorubicin
Full
Hong YAN1, 2, 3, Lyudong GONG1, 2, 3, Chengzhi ZHONG1, 2, 3, Zhida ZI1, 2, 3, Ting LI1, 2, 3, Desong WU1, 2, 3, Yan GUO1, 2, 3, *
Affiliations
  • 1.Yunnan Baiyao Group Co., Ltd., Kunming 650500, China
  • 2.Yunnan Institute of Materia Medica, Kunming 650111, China
  • 3.Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming 650111, China
Published: 2026-03-30 doi: 10.3969/j.issn.1005-4847.2026.03.006
Outline
收藏切换
Objective

To establish rapid-aging and cardiac-aging mouse models by intraperitoneal injection of doxorubicin (DOX) at different doses and frequencies, to optimize model-evaluation indices, and provide disease-model support for anti-aging drug evaluation.

Methods

(1) For the rapid-aging model, mice were divided into model 1 (5 mg/kg, once every 7 d), model 2 (8 mg/kg, once every 10 d), model 3 (8 mg/kg, once every 7 d), model 4 (10 mg/kg, once every 10 d), and model 5 (10 mg/kg, once every 7 d) groups. DOX was administered by three intraperitoneal injections and mice were observed continuously for 60 d to record survival rate. (2) For the cardiac-aging model, mice were divided into control, model-1 (2 mg/kg), model-2 (5 mg/kg), model-3 (8 mg/kg), and model-4 (10 mg/kg) groups. Injections were given twice, once every 10 d, for 30 d. After completion, ejection fraction (EF), fractional shortening (FS), and peak blood flow velocity were evaluated by small animal high-frequency ultrasound imaging. Serum levels of creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), interleukin (IL)-6, and IL-1β, and myocardial-tissue levels of superoxide dismutase (SOD), malondialdehyde (MDA), glutathione peroxidase (GSH-Px), succinate dehydrogenase, and catalase were measured. Myocardial tissue pathology, fibronectin, β-galactosidase staining (β-gal), and p16 protein, along with other cardiac aging-related indicators, were assessed.

Results

(1) In the rapid-aging mouse model, body mass and survival rate showed significant downward trends in all modeling groups. Decreases in body mass and survival rate became more pronounced with increasing DOX dose and shortened modeling interval. (2) In the cardiac-aging model, compared with the control group, DOX 2, 5, 8, and 10 mg/kg significantly increased LDH levels (P < 0.01) and decreased GSH-Px activity (P < 0.05 or P < 0.01), and DOX 5, 8, and 10 mg/kg significantly decreased body mass (P <0.01), EF, FS, and peak blood flow velocity (P < 0.05 or P < 0.01). Serum IL-6 levels were significantly increased, SOD content was significantly decreased, and β-galactosidase and p16 protein expression levels were significantly elevated (P < 0.05 or P < 0.01). Myocardial tissue showed hydropic and vacuolar degeneration. DOX 8 and 10 mg/kg also significantly increased CK-MB levels and cardiac fibrosis, and DOX 10 mg/kg increased IL-1β and MDA contents (P < 0.01).

Conclusions

Intraperitoneal injection of DOX 10 mg/kg once every 10 d for three injections successfully established a rapid-aging mouse model, while intraperitoneal injection of DOX 5 or 8 mg/kg once every 10 d for two injections successfully established a cardiac-aging mouse model, which induced changes in cardiac function, myocardial enzymes, inflammation, oxidative stress, aging markers, cardiac pathology, and fibrosis consistent with physiological and pathological characteristics of cardiac aging.

aging  /  cardiac aging  /  mice  /  doxorubicin  /  different doses
Hong YAN, Lyudong GONG, Chengzhi ZHONG, Zhida ZI, Ting LI, Desong WU, Yan GUO. Construction of an aging mouse model induced by different doses of doxorubicin[J]. Acta Laboratorium Animalis Scientia Sinica, 2026 , 34 (3) : 371 -381 . DOI: 10.3969/j.issn.1005-4847.2026.03.006
  • Key Research and Development Project of Yunnan Province(202203AC100008)
  • Yunnan Fundamental Research Projects(202401AT070155)
Year 2026 volume 34 Issue 3
PDF
90
20
Cite this Article
BibTeX
Article Info
doi: 10.3969/j.issn.1005-4847.2026.03.006
  • Receive Date:2025-09-03
  • Online Date:2026-08-08
  • Published:2026-03-30
Article Data
Affiliations
History
  • Received:2025-09-03
Funding
Key Research and Development Project of Yunnan Province(202203AC100008)
Yunnan Fundamental Research Projects(202401AT070155)
Affiliations
    1.Yunnan Baiyao Group Co., Ltd., Kunming 650500, China
    2.Yunnan Institute of Materia Medica, Kunming 650111, China
    3.Yunnan Province Company Key Laboratory for TCM and Ethnic Drug of New Drug Creation, Kunming 650111, China

Corresponding:

GUO Yan. E-mail:
References
Share
https://castjournals.cast.org.cn/joweb/zgsydwxb/EN/10.3969/j.issn.1005-4847.2026.03.006
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT